The Europe medication-assisted treatment is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the medication-assisted treatment (MAT) market will grow at a CAGR of 8.7% from 2022 to 2029.
Market Definition
Medication-assisted treatment (MAT) involves using medications, combined with counselling and behavioural therapies, to provide a complete patient approach for treating substance use disorders. The aim of MAT is proper recovery, which includes improved patient survival, increased treatment retention, reduced illicit response, and a rise in pregnancy outcomes among women. For opioid overdose prevention medication, naloxone is used to prevent opioid overdose by reversing the toxic effects of the overdose. According to the World Health Organization (WHO) and Substance Abuse and Mental Health Services Administration (SAMHSA) naloxone is one of many medications considered essential to a functioning health care system.
Market Segmentation
By Type (Medication and Therapy), Products (Buprenorphine and Naloxone, Naltrexone, Buprenorphine, Methadone, Naloxone, Disulfiram and Acamprosate), Drug Type (Generics and Branded), Dosage Form (Immediate Release and Extended Release), Route of Administration (Oral, Parenteral and Others), Population Type (Adults and Teenage), End User (Rehabilitation Clinics, Hospitals, Specialty Centres, Homecare and Others) Distribution Channel (Hospital Pharmacy, Direct Tender, Retail Pharmacy, Online Pharmacy and Others)
Medication-Assisted Treatment (MAT) Market Country Level Analysis
The countries covered Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Norway, Poland, Hungary, Lithuania, Austria, Ireland and Rest of Europe.
Medication-Assisted Treatment (MAT) Market Regional Analysis/Insights
The Europe medication-assisted treatment (MAT) market is analysed and market size insights and trends are provided by regions, product type, type, application, workflow, end user and distribution channel as referenced above.
Germany is expected to dominate the market due to the presence of rehabilitation centres for MAT, the rise in reimbursement, and the rise of pharmaceutical companies.
Get full Access of Sample Report:- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-medication-assisted-treatment-mat-market
Major Toc Of The Report
Chapter One:- Market Introduction
Chapter Two_ Market Definition
Chapter Three:- Market Segmentation
Chapter Four:- Market Analysis
Get TOC Details:-https://www.databridgemarketresearch.com/toc/?dbmr=europe-medication-assisted-treatment-mat-market
Browse Related Reports: -
Global Medication-Assisted Treatment (MAT) Market
Europe Medication-Assisted Treatment (MAT) Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818